2019

1. Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles

   ACS Chemical Neuroscience, Vol. 10, Núm. 9, pp. 4076-4101

2. Taking advantage of the selectivity of histone deacetylases and phosphodiesterase inhibitors to design better therapeutic strategies to treat Alzheimer's disease

   Frontiers in Aging Neuroscience, Vol. 11, Núm. JUN